Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today ...

ArteraAI Breast is designed to stratify breast cancer patients into high- and low-risk groups to guide treatment decisions.

Vention and Universal Robots, a Teradyne Robotics company, will showcase integrated end-of-line packaging automation ...

RVL Pharmaceuticals Inc. and its affiliates (together, "RVL") announced strong first-quarter performance, with total revenue up double-digit year-over-year, led by Upneeq®. Results reflect ...

On May 6, Hope Air marks 40 years of helping Canadians who must travel long distances to reach hospitals for vital medical treatment. As a national charity, Hope Air provides travel support to those ...

Artificial intelligence specialist Artera has won FDA approval for AI-powered software that can help guide the management of patients diagnosed with localised prostate cancer. ArteraAI Prostate is ...

There has been a spate of attacks on ships near the Horn of Africa in recent weeks, raising fears of a resurgence in Somali ...

The test imputes risk of metastasis in early-stage hormone receptor-positive, HER2-negative breast cancers to help tailor treatment.

(UroToday.com) The 2026 Advanced Prostate Cancer Consensus Conference (APCCC) meeting featured a high-risk and locally advanced prostate cancer session and a presentation by Dr. Jason Efstathiou ...

Eastport Critical Metals Corp. is pleased to provide an operational update covering the period from which the Company ...